Results 171 to 180 of about 16,801,423 (422)
The Omniglot challenge: a 3-year progress report [PDF]
B. Lake, R. Salakhutdinov, J. Tenenbaum
semanticscholar +1 more source
Toward market design in practice: a progress report. [PDF]
Kojima F, Odahara H.
europepmc +1 more source
Patient‐derived xenografts (PDXs) can be improved by implantation of a humanized niche. We tested different biomaterials and approaches, and demonstrate that the combination of an injectable biomaterial for scaffold creation plus an intravenous route for acute myeloid leukemia (AML) xenotransplantation provide the most convenient and robust approach to
Daniel Busa+13 more
wiley +1 more source
The WINGS Survey: a progress report
A two-band (B and V) wide-field imaging survey of a complete, all-sky X-ray selected sample of 78 clusters in the redshift range z=0.04-0.07 is presented. The aim of this survey is to provide the astronomical community with a complete set of homogeneous,
Bettoni, D.+9 more
core
Quark masses in QCD: a progress report
Recent progress on QCD sum rule determinations of the light and heavy quark masses is reported. In the light quark sector a major breakthrough has been made recently in connection with the historical systematic uncertainties due to a lack of experimental
Bordes J.+9 more
core +1 more source
Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cancer
This study employed targeted metabolomic profiling to identify 302 distinct metabolites present in platelet‐rich plasma (PRP), revealing aberrant metabolic profiles amongst individuals diagnosed with colorectal cancer (CRC). Compared to carcinoembryonic antigen (CEA) and cancer antigen 19‐9 (CA199), our metabolite panel showed improved sensitivity ...
Zuojian Hu+7 more
wiley +1 more source
Progress on Drinking Water and Sanitation: 2012 Update [PDF]
The report announces that the world has met the Millennium Development Goal (MDG) target of halving the proportion of people without access to safe drinking water, well ahead of schedule.
core
KMT2A degradation is observed in decitabine‐responsive acute lymphoblastic leukemia cells
We demonstrate that decitabine (DEC) not only degrades the DNA methyltransferase DNMT1 but also the leukemic driver lysine methyltransferase KMT2A likely due to structural similarity of the DNA‐binding CXXC domains. DEC influences KMT2A downstream processes and synergizes with menin inhibitor revumenib (REV) to decrease leukemic cell proliferation, and
Luisa Brock+10 more
wiley +1 more source